Eric Pauwels, CHIEF BUSINESS OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 8,836 shares at $58.50 ($517K) on 2023-05-17, disclosed to the SEC on 2023-05-19.
Scheduled sale ($517k) by CHIEF BUSINESS OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.50 | 7,248 | $424K | 82.0% |
| 2 | $58.52 | 800 | $47K | 9.1% |
| 3 | $58.71 | 788 | $46K | 8.9% |
| Total | $58.52 avg | 8,836 | $517K | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $566K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-23 | $3.0M | — | Filing → |